Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04358510 · ClinicalTrials.gov registry record
COVID-19 Mortality Prediction Model
A clinical trial, sponsored by Dascena.
- Completed
- Registry status
- 114
- Enrollment target
NCT04358510: Completed study, sponsored by Dascena.
NCT04358510 is a clinical trial that has completed, run by Dascena. The registered enrollment target is 114 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04358510 has completed, sponsored by Dascena.
- COMPLETED
- Registry status
- 114 participants
- Enrollment target
Study Summary
The objective of this study is to develop and evaluate an algorithm which accurately predicts mortality in COVID-19, pneumonia and mechanically ventilated ICU patients.
Primary Outcome
Deceased or not deceased
Interventions
- DEVICE COViage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2020-04-01 |
| Est. Completion | 2020-04-17 |
What the finished NCT04358510 record still lists
NCT04358510 is an observational study that tracks outcomes without assigning an intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which COViage is the first listed.
NCT04358510 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04358510 about?
NCT04358510 is a clinical study titled "COVID-19 Mortality Prediction Model". The objective of this study is to develop and evaluate an algorithm which accurately predicts mortality in COVID-19, pneumonia and mechanically ventilated ICU patients.
What is the current status of trial NCT04358510?
This trial is currently completed. The enrollment target is 114 participants. The study started on 2020-04-01. Estimated completion is 2020-04-17.
What interventions are being tested in trial NCT04358510?
The interventions under investigation include: COViage (DEVICE).
Who is sponsoring clinical trial NCT04358510?
This trial is sponsored by Dascena, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI